Bottom line: AOD-9604 offers a targeted, non-stimulant approach to fat loss and metabolic support best suited as a supportive therapy, not a standalone solution
During his career, he has held roles at Foresters Financial, Strayer University, Minnesota Life, Securian Financial Services, Delaware Valley Advisors, Bridgemark Wealth Management, and Fidelity
Quick Action : Injectables act faster compared to oral supplements, ideal for individuals with significant deficiencies
Clinical trials in humans evaluating lipotropic injections remain scarce
Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network Open (2022) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Carnitine, National Institutes of Health (2023) Effects of three treatment modalities (diet, myoinositol, or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome, European Review for Medical and Pharmacological Sciences (2019) Who can perform semaglutide treatments?, American Med Spa Association (2023) Using fat-dissolving injections that are not FDA-approved can be harmful, U.S
Megaloblastic anemia is one such deficiency, a macrocytic anemia that causes bone marrow to create very large red blood cells
